Evidence map›Paper›PMID 40479023›Full record

ArticleJournal of the knowledge economy2023

Conceptual Bases of a Quantitative Method for Assessing the Transferability of Medical Technologies Across the Rich-Poor Divide.

Vuk Uskoković

Abstract read
In one paragraph

Article in Journal of the knowledge economy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Vuk UskokovićAdvanced Materials and Nanobiotechnology Laboratory, TardigradeNano LLC, Irvine, CA 92604 USA.ORCID 0000-0003-3256-1606

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In spite of the global advancements in science and technology, the disparity in the quality of life across the globe continues to increase, particularly so in terms of the access to cutting-edge medical technologies. Opportune transfer of technologies across the rich-poor divide lessens the global economic inequalities and fosters the sustainability of the global economy, but not all technologies are equally transferrable across this gap. Here, a method for quantifying the transferability of technologies has been postulated and preliminarily tested by considering twelve state-of-the-art medical technologies and three comparatively impoverished regions of the world: West Bengal in India, Xinjiang in China, and the former Yugoslav state of Montenegro. The results of the analysis demonstrate that neither the gross economic productivity of the region of interest nor its level of poverty can be the sole determinants of the transferability of technologies. Rather, a complex network of scientific, technological, infrastructural, socioeconomic, and cultural factors defines the extent of transferability of new technologies across the rich-poor divide. The proposed model helps to discern which of these factors represent the most critical hindrances in the transfer of technologies. It is argued that the most dependable technologies to transfer are old and proven ones, but the best ones for ameliorating the rich-poor divide are juvenile technologies in formative stages of their development, which also happen to be employing simplistic ingenuity and resourcefulness in their design. The analysis performed here makes it apparent that models for assessing the social value of technologies should inextricably tie the scientific factors with the socioeconomic and humanistic. Countless technical models of various natures could be devised with this holistic principle in mind.

Indexed as

BiotechnologyMedical devicesNanotechnologyTechnology transfer

Identifiers

PMID40479023
PMCPMC10052303

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.